Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout?

TheFly reported connected June 24 that Raymond James initiated sum of MPLT with a Strong Buy standing and a $46 terms target. The steadfast highlighted Cobenfy arsenic a important advancement successful schizophrenia attraction but noted challenges related to attraction persistence. Raymond James sees imaginable upside up of the Phase 2 ZEPHYR proceedings readout for ML-007C-MA, expected by mid-August. The steadfast besides identified MPLT's Alzheimer's illness psychosis programme arsenic a imaginable worth driver, contempt constricted capitalist attraction toward Alzheimer 's-focused opportunities.

Separately, connected June 22, MapLight Therapeutics, Inc. (NASDAQ:MPLT) announced topline findings from its Phase 2 IRIS proceedings evaluating ML-004 successful autism spectrum upset (ASD). The survey enrolled 161 participants and assessed aggregate measures, including societal connection and irritability outcomes. While the proceedings did not execute its superior endpoint related to societal connection betterment astatine Week 12, a prespecified investigation showed ML-004 produced clinically meaningful improvements successful irritability among adolescents with mean oregon higher baseline irritability compared with placebo. The attraction besides demonstrated affirmative trends connected clinician-rated irritability measures. ML-004 was mostly good tolerated, with mostly mild-to-moderate adverse events and nary terrible information concerns reported successful treated participants.

MapLight Therapeutics, Inc. (NASDAQ:MPLT) is simply a clinical-stage biopharmaceutical institution processing targeted treatments for cardinal tense strategy disorders utilizing precocious neurotechnologies.

While we admit the imaginable of MPLT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.